Senior insider sale
Chief Financial Officer at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$389.9K
5.94K shares
What this filing means
GORDON STEPHEN plans to sell 5.94K shares of TRANSMEDICS GROUP, INC. valued at approximately $389.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2025ACC: 0001959173-25-001625
Officer· Chief Financial Officer
Since May 2019
5.94K
Shares to sell
$389.9K
Approx. market value
5.94K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
RSU
N/A
2/23/2025
2.92KRSU
N/A
2/20/2025
3.03KTotal acquired5.94K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2025 | RSU N/A | 2.92K | — |
2/20/2025 | RSU N/A | 3.03K | — |
| Total | 5.94K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.94K
Market value
$389.9K
3/4/2025
Total
Units
5.94K
Value
$389.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/4/2025 | 5.94K | $389.9K | NASDAQ | Planned |
| Total | 5.94K | $389.9K | ||